img

Global Drug Modeling Softwares Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Software

Publisher : MRA | Format : PDF

Global Drug Modeling Softwares Market Insights, Forecast to 2034

Drug Modeling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key a role in the development of novel drugs. Software based methods such as molecular modeling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for the investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. Additionally, appropriate implementation of these techniques may help in reducing drug designing and development cost.
Market Analysis and InsightsGlobal Drug Modeling Softwares Market
The global Drug Modeling Softwares market is projected to grow from US$ million in 2023 to US$ million by 2033, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Drug Modeling Softwares is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The China market for Drug Modeling Softwares is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The Europe market for Drug Modeling Softwares is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The global key companies of Drug Modeling Softwares include JSR Corporation(Crown Bioscience), Chemical Computing Group ULC, Nimbus Therapeutics, Schrodinger, Inc, Genedata AG, Biognos AB, Compugen Ltd, Dassault Systemes and Acellera, etc. in 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Drug Modeling Softwares market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2023, estimates for 2023, and projections of CAGR through 2033.
This report researches the key producers of Drug Modeling Softwares, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Drug Modeling Softwares, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug Modeling Softwares revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Drug Modeling Softwares market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2033. Evaluation and forecast the market size for Drug Modeling Softwares revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including JSR Corporation(Crown Bioscience), Chemical Computing Group ULC, Nimbus Therapeutics, Schrodinger, Inc, Genedata AG, Biognos AB, Compugen Ltd, Dassault Systemes and Acellera, etc.



By Company


JSR Corporation(Crown Bioscience)
Chemical Computing Group ULC
Nimbus Therapeutics
Schrodinger, Inc
Genedata AG
Biognos AB
Compugen Ltd
Dassault Systemes
Acellera
Instem(Leadscope)
Segment by Type
Database
Software
Others

Segment by Application


Drug Discovery and Development
Computational Physiological Medicine
Disease Modelling
Medical Imaging
Predictive Analysis of Drug Targets
Simulation Software
Cellular Simulation
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Drug Modeling Softwares in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Drug Modeling Softwares companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Modeling Softwares revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Modeling Softwares Market Size Growth Rate by Type, 2018 VS 2023 VS 2033
1.2.2 Database
1.2.3 Software
1.2.4 Others
1.3 Market by Application
1.3.1 Global Drug Modeling Softwares Market Size Growth Rate by Application, 2018 VS 2023 VS 2033
1.3.2 Drug Discovery and Development
1.3.3 Computational Physiological Medicine
1.3.4 Disease Modelling
1.3.5 Medical Imaging
1.3.6 Predictive Analysis of Drug Targets
1.3.7 Simulation Software
1.3.8 Cellular Simulation
1.3.9 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Modeling Softwares Market Perspective (2018-2033)
2.2 Global Drug Modeling Softwares Growth Trends by Region
2.2.1 Drug Modeling Softwares Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 Drug Modeling Softwares Historic Market Size by Region (2018-2023)
2.2.3 Drug Modeling Softwares Forecasted Market Size by Region (2024-2033)
2.3 Drug Modeling Softwares Market Dynamics
2.3.1 Drug Modeling Softwares Industry Trends
2.3.2 Drug Modeling Softwares Market Drivers
2.3.3 Drug Modeling Softwares Market Challenges
2.3.4 Drug Modeling Softwares Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Drug Modeling Softwares by Players
3.1.1 Global Drug Modeling Softwares Revenue by Players (2018-2023)
3.1.2 Global Drug Modeling Softwares Revenue Market Share by Players (2018-2023)
3.2 Global Drug Modeling Softwares Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drug Modeling Softwares, Ranking by Revenue, 2021 VS 2023 VS 2023
3.4 Global Drug Modeling Softwares Market Concentration Ratio
3.4.1 Global Drug Modeling Softwares Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Modeling Softwares Revenue in 2023
3.5 Global Key Players of Drug Modeling Softwares Head office and Area Served
3.6 Global Key Players of Drug Modeling Softwares, Product and Application
3.7 Global Key Players of Drug Modeling Softwares, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Modeling Softwares Breakdown Data by Type
4.1 Global Drug Modeling Softwares Historic Market Size by Type (2018-2023)
4.2 Global Drug Modeling Softwares Forecasted Market Size by Type (2024-2033)
5 Drug Modeling Softwares Breakdown Data by Application
5.1 Global Drug Modeling Softwares Historic Market Size by Application (2018-2023)
5.2 Global Drug Modeling Softwares Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Drug Modeling Softwares Market Size (2018-2033)
6.2 North America Drug Modeling Softwares Market Size by Type
6.2.1 North America Drug Modeling Softwares Market Size by Type (2018-2023)
6.2.2 North America Drug Modeling Softwares Market Size by Type (2024-2033)
6.2.3 North America Drug Modeling Softwares Market Share by Type (2018-2033)
6.3 North America Drug Modeling Softwares Market Size by Application
6.3.1 North America Drug Modeling Softwares Market Size by Application (2018-2023)
6.3.2 North America Drug Modeling Softwares Market Size by Application (2024-2033)
6.3.3 North America Drug Modeling Softwares Market Share by Application (2018-2033)
6.4 North America Drug Modeling Softwares Market Size by Country
6.4.1 North America Drug Modeling Softwares Market Size by Country: 2018 VS 2023 VS 2033
6.4.2 North America Drug Modeling Softwares Market Size by Country (2018-2023)
6.4.3 North America Drug Modeling Softwares Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Drug Modeling Softwares Market Size (2018-2033)
7.2 Europe Drug Modeling Softwares Market Size by Type
7.2.1 Europe Drug Modeling Softwares Market Size by Type (2018-2023)
7.2.2 Europe Drug Modeling Softwares Market Size by Type (2024-2033)
7.2.3 Europe Drug Modeling Softwares Market Share by Type (2018-2033)
7.3 Europe Drug Modeling Softwares Market Size by Application
7.3.1 Europe Drug Modeling Softwares Market Size by Application (2018-2023)
7.3.2 Europe Drug Modeling Softwares Market Size by Application (2024-2033)
7.3.3 Europe Drug Modeling Softwares Market Share by Application (2018-2033)
7.4 Europe Drug Modeling Softwares Market Size by Country
7.4.1 Europe Drug Modeling Softwares Market Size by Country: 2018 VS 2023 VS 2033
7.4.2 Europe Drug Modeling Softwares Market Size by Country (2018-2023)
7.4.3 Europe Drug Modeling Softwares Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Drug Modeling Softwares Market Size (2018-2033)
8.2 China Drug Modeling Softwares Market Size by Type
8.2.1 China Drug Modeling Softwares Market Size by Type (2018-2023)
8.2.2 China Drug Modeling Softwares Market Size by Type (2024-2033)
8.2.3 China Drug Modeling Softwares Market Share by Type (2018-2033)
8.3 China Drug Modeling Softwares Market Size by Application
8.3.1 China Drug Modeling Softwares Market Size by Application (2018-2023)
8.3.2 China Drug Modeling Softwares Market Size by Application (2024-2033)
8.3.3 China Drug Modeling Softwares Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Drug Modeling Softwares Market Size (2018-2033)
9.2 Asia Drug Modeling Softwares Market Size by Type
9.2.1 Asia Drug Modeling Softwares Market Size by Type (2018-2023)
9.2.2 Asia Drug Modeling Softwares Market Size by Type (2024-2033)
9.2.3 Asia Drug Modeling Softwares Market Share by Type (2018-2033)
9.3 Asia Drug Modeling Softwares Market Size by Application
9.3.1 Asia Drug Modeling Softwares Market Size by Application (2018-2023)
9.3.2 Asia Drug Modeling Softwares Market Size by Application (2024-2033)
9.3.3 Asia Drug Modeling Softwares Market Share by Application (2018-2033)
9.4 Asia Drug Modeling Softwares Market Size by Region
9.4.1 Asia Drug Modeling Softwares Market Size by Region: 2018 VS 2023 VS 2033
9.4.2 Asia Drug Modeling Softwares Market Size by Region (2018-2023)
9.4.3 Asia Drug Modeling Softwares Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Drug Modeling Softwares Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Drug Modeling Softwares Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drug Modeling Softwares Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Drug Modeling Softwares Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Drug Modeling Softwares Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Drug Modeling Softwares Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drug Modeling Softwares Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Drug Modeling Softwares Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Drug Modeling Softwares Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Drug Modeling Softwares Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drug Modeling Softwares Market Size by Country: 2018 VS 2023 VS 2033
10.4.2 Middle East, Africa, and Latin America Drug Modeling Softwares Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Drug Modeling Softwares Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 JSR Corporation(Crown Bioscience)
11.1.1 JSR Corporation(Crown Bioscience) Company Details
11.1.2 JSR Corporation(Crown Bioscience) Business Overview
11.1.3 JSR Corporation(Crown Bioscience) Drug Modeling Softwares Introduction
11.1.4 JSR Corporation(Crown Bioscience) Revenue in Drug Modeling Softwares Business (2018-2023)
11.1.5 JSR Corporation(Crown Bioscience) Recent Developments
11.2 Chemical Computing Group ULC
11.2.1 Chemical Computing Group ULC Company Details
11.2.2 Chemical Computing Group ULC Business Overview
11.2.3 Chemical Computing Group ULC Drug Modeling Softwares Introduction
11.2.4 Chemical Computing Group ULC Revenue in Drug Modeling Softwares Business (2018-2023)
11.2.5 Chemical Computing Group ULC Recent Developments
11.3 Nimbus Therapeutics
11.3.1 Nimbus Therapeutics Company Details
11.3.2 Nimbus Therapeutics Business Overview
11.3.3 Nimbus Therapeutics Drug Modeling Softwares Introduction
11.3.4 Nimbus Therapeutics Revenue in Drug Modeling Softwares Business (2018-2023)
11.3.5 Nimbus Therapeutics Recent Developments
11.4 Schrodinger, Inc
11.4.1 Schrodinger, Inc Company Details
11.4.2 Schrodinger, Inc Business Overview
11.4.3 Schrodinger, Inc Drug Modeling Softwares Introduction
11.4.4 Schrodinger, Inc Revenue in Drug Modeling Softwares Business (2018-2023)
11.4.5 Schrodinger, Inc Recent Developments
11.5 Genedata AG
11.5.1 Genedata AG Company Details
11.5.2 Genedata AG Business Overview
11.5.3 Genedata AG Drug Modeling Softwares Introduction
11.5.4 Genedata AG Revenue in Drug Modeling Softwares Business (2018-2023)
11.5.5 Genedata AG Recent Developments
11.6 Biognos AB
11.6.1 Biognos AB Company Details
11.6.2 Biognos AB Business Overview
11.6.3 Biognos AB Drug Modeling Softwares Introduction
11.6.4 Biognos AB Revenue in Drug Modeling Softwares Business (2018-2023)
11.6.5 Biognos AB Recent Developments
11.7 Compugen Ltd
11.7.1 Compugen Ltd Company Details
11.7.2 Compugen Ltd Business Overview
11.7.3 Compugen Ltd Drug Modeling Softwares Introduction
11.7.4 Compugen Ltd Revenue in Drug Modeling Softwares Business (2018-2023)
11.7.5 Compugen Ltd Recent Developments
11.8 Dassault Systemes
11.8.1 Dassault Systemes Company Details
11.8.2 Dassault Systemes Business Overview
11.8.3 Dassault Systemes Drug Modeling Softwares Introduction
11.8.4 Dassault Systemes Revenue in Drug Modeling Softwares Business (2018-2023)
11.8.5 Dassault Systemes Recent Developments
11.9 Acellera
11.9.1 Acellera Company Details
11.9.2 Acellera Business Overview
11.9.3 Acellera Drug Modeling Softwares Introduction
11.9.4 Acellera Revenue in Drug Modeling Softwares Business (2018-2023)
11.9.5 Acellera Recent Developments
11.10 Instem(Leadscope)
11.10.1 Instem(Leadscope) Company Details
11.10.2 Instem(Leadscope) Business Overview
11.10.3 Instem(Leadscope) Drug Modeling Softwares Introduction
11.10.4 Instem(Leadscope) Revenue in Drug Modeling Softwares Business (2018-2023)
11.10.5 Instem(Leadscope) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drug Modeling Softwares Market Size Growth Rate by Type (US$ Million), 2018 VS 2023 VS 2033
Table 2. Key Players of Database
Table 3. Key Players of Software
Table 4. Key Players of Others
Table 5. Global Drug Modeling Softwares Market Size Growth Rate by Application (US$ Million), 2018 VS 2023 VS 2033
Table 6. Global Drug Modeling Softwares Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 7. Global Drug Modeling Softwares Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Drug Modeling Softwares Market Share by Region (2018-2023)
Table 9. Global Drug Modeling Softwares Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Drug Modeling Softwares Market Share by Region (2024-2033)
Table 11. Drug Modeling Softwares Market Trends
Table 12. Drug Modeling Softwares Market Drivers
Table 13. Drug Modeling Softwares Market Challenges
Table 14. Drug Modeling Softwares Market Restraints
Table 15. Global Drug Modeling Softwares Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Drug Modeling Softwares Revenue Share by Players (2018-2023)
Table 17. Global Top Drug Modeling Softwares by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Modeling Softwares as of 2023)
Table 18. Global Drug Modeling Softwares Industry Ranking 2021 VS 2023 VS 2023
Table 19. Global 5 Largest Players Market Share by Drug Modeling Softwares Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Drug Modeling Softwares, Headquarters and Area Served
Table 21. Global Key Players of Drug Modeling Softwares, Product and Application
Table 22. Global Key Players of Drug Modeling Softwares, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Drug Modeling Softwares Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Drug Modeling Softwares Revenue Market Share by Type (2018-2023)
Table 26. Global Drug Modeling Softwares Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Drug Modeling Softwares Revenue Market Share by Type (2024-2033)
Table 28. Global Drug Modeling Softwares Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Drug Modeling Softwares Revenue Share by Application (2018-2023)
Table 30. Global Drug Modeling Softwares Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Drug Modeling Softwares Revenue Share by Application (2024-2033)
Table 32. North America Drug Modeling Softwares Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Drug Modeling Softwares Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Drug Modeling Softwares Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Drug Modeling Softwares Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Drug Modeling Softwares Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 37. North America Drug Modeling Softwares Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Drug Modeling Softwares Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Drug Modeling Softwares Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Drug Modeling Softwares Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Drug Modeling Softwares Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Drug Modeling Softwares Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Drug Modeling Softwares Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 44. Europe Drug Modeling Softwares Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Drug Modeling Softwares Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Drug Modeling Softwares Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Drug Modeling Softwares Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Drug Modeling Softwares Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Drug Modeling Softwares Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Drug Modeling Softwares Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Drug Modeling Softwares Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Drug Modeling Softwares Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Drug Modeling Softwares Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Drug Modeling Softwares Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 55. Asia Drug Modeling Softwares Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Drug Modeling Softwares Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Drug Modeling Softwares Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Drug Modeling Softwares Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Drug Modeling Softwares Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Drug Modeling Softwares Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Drug Modeling Softwares Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 62. Middle East, Africa, and Latin America Drug Modeling Softwares Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Drug Modeling Softwares Market Size by Country (2024-2033) & (US$ Million)
Table 64. JSR Corporation(Crown Bioscience) Company Details
Table 65. JSR Corporation(Crown Bioscience) Business Overview
Table 66. JSR Corporation(Crown Bioscience) Drug Modeling Softwares Product
Table 67. JSR Corporation(Crown Bioscience) Revenue in Drug Modeling Softwares Business (2018-2023) & (US$ Million)
Table 68. JSR Corporation(Crown Bioscience) Recent Developments
Table 69. Chemical Computing Group ULC Company Details
Table 70. Chemical Computing Group ULC Business Overview
Table 71. Chemical Computing Group ULC Drug Modeling Softwares Product
Table 72. Chemical Computing Group ULC Revenue in Drug Modeling Softwares Business (2018-2023) & (US$ Million)
Table 73. Chemical Computing Group ULC Recent Developments
Table 74. Nimbus Therapeutics Company Details
Table 75. Nimbus Therapeutics Business Overview
Table 76. Nimbus Therapeutics Drug Modeling Softwares Product
Table 77. Nimbus Therapeutics Revenue in Drug Modeling Softwares Business (2018-2023) & (US$ Million)
Table 78. Nimbus Therapeutics Recent Developments
Table 79. Schrodinger, Inc Company Details
Table 80. Schrodinger, Inc Business Overview
Table 81. Schrodinger, Inc Drug Modeling Softwares Product
Table 82. Schrodinger, Inc Revenue in Drug Modeling Softwares Business (2018-2023) & (US$ Million)
Table 83. Schrodinger, Inc Recent Developments
Table 84. Genedata AG Company Details
Table 85. Genedata AG Business Overview
Table 86. Genedata AG Drug Modeling Softwares Product
Table 87. Genedata AG Revenue in Drug Modeling Softwares Business (2018-2023) & (US$ Million)
Table 88. Genedata AG Recent Developments
Table 89. Biognos AB Company Details
Table 90. Biognos AB Business Overview
Table 91. Biognos AB Drug Modeling Softwares Product
Table 92. Biognos AB Revenue in Drug Modeling Softwares Business (2018-2023) & (US$ Million)
Table 93. Biognos AB Recent Developments
Table 94. Compugen Ltd Company Details
Table 95. Compugen Ltd Business Overview
Table 96. Compugen Ltd Drug Modeling Softwares Product
Table 97. Compugen Ltd Revenue in Drug Modeling Softwares Business (2018-2023) & (US$ Million)
Table 98. Compugen Ltd Recent Developments
Table 99. Dassault Systemes Company Details
Table 100. Dassault Systemes Business Overview
Table 101. Dassault Systemes Drug Modeling Softwares Product
Table 102. Dassault Systemes Revenue in Drug Modeling Softwares Business (2018-2023) & (US$ Million)
Table 103. Dassault Systemes Recent Developments
Table 104. Acellera Company Details
Table 105. Acellera Business Overview
Table 106. Acellera Drug Modeling Softwares Product
Table 107. Acellera Revenue in Drug Modeling Softwares Business (2018-2023) & (US$ Million)
Table 108. Acellera Recent Developments
Table 109. Instem(Leadscope) Company Details
Table 110. Instem(Leadscope) Business Overview
Table 111. Instem(Leadscope) Drug Modeling Softwares Product
Table 112. Instem(Leadscope) Revenue in Drug Modeling Softwares Business (2018-2023) & (US$ Million)
Table 113. Instem(Leadscope) Recent Developments
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Modeling Softwares Market Size Growth Rate by Type, 2018 VS 2023 VS 2033 (US$ Million)
Figure 2. Global Drug Modeling Softwares Market Share by Type: 2023 VS 2033
Figure 3. Database Features
Figure 4. Software Features
Figure 5. Others Features
Figure 6. Global Drug Modeling Softwares Market Size Growth Rate by Application, 2018 VS 2023 VS 2033 (US$ Million)
Figure 7. Global Drug Modeling Softwares Market Share by Application: 2023 VS 2033
Figure 8. Drug Discovery and Development Case Studies
Figure 9. Computational Physiological Medicine Case Studies
Figure 10. Disease Modelling Case Studies
Figure 11. Medical Imaging Case Studies
Figure 12. Predictive Analysis of Drug Targets Case Studies
Figure 13. Simulation Software Case Studies
Figure 14. Cellular Simulation Case Studies
Figure 15. Others Case Studies
Figure 16. Drug Modeling Softwares Report Years Considered
Figure 17. Global Drug Modeling Softwares Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 18. Global Drug Modeling Softwares Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 19. Global Drug Modeling Softwares Market Share by Region: 2023 VS 2033
Figure 20. Global Drug Modeling Softwares Market Share by Players in 2023
Figure 21. Global Top Drug Modeling Softwares Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Modeling Softwares as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Drug Modeling Softwares Revenue in 2023
Figure 23. North America Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. North America Drug Modeling Softwares Market Share by Type (2018-2033)
Figure 25. North America Drug Modeling Softwares Market Share by Application (2018-2033)
Figure 26. North America Drug Modeling Softwares Market Share by Country (2018-2033)
Figure 27. United States Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Canada Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Europe Drug Modeling Softwares Market Size YoY (2018-2033) & (US$ Million)
Figure 30. Europe Drug Modeling Softwares Market Share by Type (2018-2033)
Figure 31. Europe Drug Modeling Softwares Market Share by Application (2018-2033)
Figure 32. Europe Drug Modeling Softwares Market Share by Country (2018-2033)
Figure 33. Germany Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. France Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. U.K. Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Italy Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Russia Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Nordic Countries Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. China Drug Modeling Softwares Market Size YoY (2018-2033) & (US$ Million)
Figure 40. China Drug Modeling Softwares Market Share by Type (2018-2033)
Figure 41. China Drug Modeling Softwares Market Share by Application (2018-2033)
Figure 42. Asia Drug Modeling Softwares Market Size YoY (2018-2033) & (US$ Million)
Figure 43. Asia Drug Modeling Softwares Market Share by Type (2018-2033)
Figure 44. Asia Drug Modeling Softwares Market Share by Application (2018-2033)
Figure 45. Asia Drug Modeling Softwares Market Share by Region (2018-2033)
Figure 46. Japan Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. South Korea Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. China Taiwan Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Southeast Asia Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. India Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Australia Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Drug Modeling Softwares Market Size YoY (2018-2033) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Drug Modeling Softwares Market Share by Type (2018-2033)
Figure 54. Middle East, Africa, and Latin America Drug Modeling Softwares Market Share by Application (2018-2033)
Figure 55. Middle East, Africa, and Latin America Drug Modeling Softwares Market Share by Country (2018-2033)
Figure 56. Brazil Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Mexico Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Turkey Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Saudi Arabia Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. Israel Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 61. GCC Countries Drug Modeling Softwares Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 62. JSR Corporation(Crown Bioscience) Revenue Growth Rate in Drug Modeling Softwares Business (2018-2023)
Figure 63. Chemical Computing Group ULC Revenue Growth Rate in Drug Modeling Softwares Business (2018-2023)
Figure 64. Nimbus Therapeutics Revenue Growth Rate in Drug Modeling Softwares Business (2018-2023)
Figure 65. Schrodinger, Inc Revenue Growth Rate in Drug Modeling Softwares Business (2018-2023)
Figure 66. Genedata AG Revenue Growth Rate in Drug Modeling Softwares Business (2018-2023)
Figure 67. Biognos AB Revenue Growth Rate in Drug Modeling Softwares Business (2018-2023)
Figure 68. Compugen Ltd Revenue Growth Rate in Drug Modeling Softwares Business (2018-2023)
Figure 69. Dassault Systemes Revenue Growth Rate in Drug Modeling Softwares Business (2018-2023)
Figure 70. Acellera Revenue Growth Rate in Drug Modeling Softwares Business (2018-2023)
Figure 71. Instem(Leadscope) Revenue Growth Rate in Drug Modeling Softwares Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries